Coronary Flow Reserve and Pharmacologic Stress Perfusion Imaging. Beginnings and Evolution

JACC: Cardiovascular Imaging

Volumn 2, Issue 5, 2009, Pages 664-669

  Gould, K Lance ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

coronary flow reserve; myocardial perfusion; pharmacologic stress; stenosis fluid dynamics

Indexed keywords

ANTILIPEMIC AGENT; DIPYRIDAMOLE; MACROSALB TC 99M; RUBIDIUM 82; THALLIUM 201;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR FUNCTION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY FLOW RESERVE; FLOW KINETICS; HEART PERFUSION; HUMAN; IMAGE DISPLAY; IMAGING; LIFESTYLE MODIFICATION; LOW FAT DIET; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ANIMALS; DIPYRIDAMOLE; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HEART DISEASES; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MYOCARDIAL PERFUSION IMAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; VASODILATOR AGENTS;

EID: 65549131060     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2008.12.024     Document Type: Article

References (25)

1. Gould K.L., Lipscomb K., and Hamilton G.W. A physiological basis for assessing critical coronary stenosis: instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol 33 (1974) 87-94
2. Gould K.L., Hamilton G.W., Lipscomb K., and Kennedy J.W. A method for assessing stress induced regional malperfusion during coronary arteriography: experimental validation and clinical application. Am J Cardiol 34 (1974) 557-564
3. Gregg D.E. Physiology of the coronary circulation-The George E. Brown Memorial Lecture. Circulation 27 (1963) 1128-1137
4. Winbury M.M., Losada M., Kissil D., Howe B.B., and Pensinger R.R. Pentaerythritoltetranitrate and dipyridamole on cardiac nutritive flow and blood content. Am J Physiol 220 (1971) 1558-1563
5. Gould K.L. Noninvasive assessment of coronary stenoses by myocardial imaging during coronary vasodilation. I. Physiological principles and experimental validation. Am J Cardiol 41 (1978) 267-278
6. Gould K.L., Westcott J.R., and Hamilton G.W. Noninvasive assessment of coronary stenoses by myocardial imaging during coronary vasodilation. II. Clinical methodology and feasibility. Am J Cardiol 41 (1978) 279-289
7. Albro P.C., Gould K.L., Westcott R.J., Hamilton G.W., Ritchie J.L., and Williams D.L. Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. III. Clinical trial. Am J Cardiol 42 (1978) 751-760
8. Gould K.L. Assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilatation. IV. Limits of stenosis detection by idealized, experimental, cross-sectional myocardial imaging. Am J Cardiol 42 (1978) 761-768
9. 4+ and emission computed tomography in intact dogs. Am J Cardiol 43 (1979) 200-208
10. Schelbert H.R., Wisenberg G., Phelps M.E., et al. Noninvasive assessment of coronary stenosis by myocardial imaging during pharmacologic coronary vasodilation. VI. Detection of coronary artery disease in man with intravenous N-13 ammonia and positron computed tomography. Am J Cardiol 49 (1982) 1197-1207
11. Kirkeeide R., Gould K.L., and Parsel L. Assessment of coronary stenoses by myocardial imaging during coronary vasodilation. VII. Validation of coronary flow reserve as a single integrated measure of stenosis severity accounting for all its geometric dimensions. J Am Coll Cardiol 7 (1986) 103-113
12. Gould K.L., Goldstein R.A., Mullani N., et al. Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. VIII. Feasibility of 3D cardiac positron imaging without a cyclotron using generator produced Rb-82. J Am Coll Cardiol 7 (1986) 775-792
13. Demer L.L., Gould K.L., Goldstein R.A., and Kirkeeide R.L. Diagnosis of coronary artery disease by positron emission tomography: comparison to quantitative coronary arteriography in 193 patients. Circulation 79 (1989) 825-835
14. Young D.F., Cholvin N.R., and Roth A.C. Pressure drop across artificially induced stenoses in the femoral arteries of dogs. Circ Res 36 (1975) 735-743
15. Gould K.L. Pressure-flow characteristics of coronary stenoses in intact unsedated dogs at rest and during coronary vasodilation. Circ Res 43 (1978) 242-253
16. Furchgott R.F., and Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288 (1980) 373-376
17. Gould K.L., Martucci J.P., Goldberg D.I., et al. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. Circulation 89 (1994) 1530-1538
18. Gould K.L., Ornish D., Scherwitz L., et al. Changes in myocardial perfusion abnormalities by positron emission tomography after long term, intense risk factor modification. JAMA 274 (1995) 894-901
19. Sdringola S., Nakagawa K., Nakagawa Y., et al. Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared to usual care cholesterol lowering drugs in coronary artery disease. J Am Coll Cardiol 41 (2003) 262-272
20. Sdringola S., Boccalandro F., Loghin C., and Gould K.L. Mechanisms of progression and regression of coronary artery disease by PET related to treatment intensity and clinical events at long-term follow-up. J Nucl Med 47 (2006) 59-67
21. Gould K.L., Kirkeeide R.L., and Buchi M. Coronary flow reserve as a physiological measure of stenosis severity. Part I. Relative and absolute coronary flow reserve during changing aortic pressure and cardiac workload. Part II. Determination from arteriographic stenosis dimensions under standardized conditions. J Am Coll Cardiol 15 (1990) 459-474
22. Gould K.L., Pan T., Loghin C., Johnson N., Guha A., and Sdringola S. Frequent diagnostic errors in cardiac PET-CT due to misregistration of CT attenuation and emission PET images: a definitive analysis of causes, consequences and corrections. J Nucl Med 48 (2007) 1112-1121
23. Gould K.L. Assessing progression or regression of CAD: the role of perfusion imaging. J Nucl Cardiol 12 (2005) 625-638
24. Gould K.L. Cardiac positron emission tomography. In: Willerson J.T., Cohn J.N., Wellens H.J.J., and Holmes D.R. (Eds). Cardiovascular Medicine. 3rd edition (2007), Springer, London, United Kingdom 855-869
25. Gould K.L. Positron emission tomography in the routine management of coronary artery disease. Curr Opin Cardiol 22 (2007) 422-428